Amit Hazan
Stock Analyst at Goldman Sachs
(2.10)
# 2,951
Out of 4,974 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $86.46 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.21 | -65.30% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $2.05 | +829.10% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $15.61 | -48.75% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $58.00 | +8.63% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $192.39 | +41.38% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $15.01 | +13.26% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $13.57 | +3,105.60% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $40.68 | +8.16% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $80.94 | -9.81% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $24.42 | +117.04% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $32.13 | +77.40% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $16.40 | -42.06% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $132.94 | -21.77% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $13.96 | +329.80% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $92.90 | +23.79% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $392.31 | -61.76% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $107.22 | -57.10% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $466.86 | -48.24% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $105.73 | +67.41% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $178.43 | -17.61% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.51 | +158.28% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $86.46
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.21
Upside: -65.30%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $2.05
Upside: +829.10%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.61
Upside: -48.75%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $58.00
Upside: +8.63%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $192.39
Upside: +41.38%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $15.01
Upside: +13.26%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $13.57
Upside: +3,105.60%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $40.68
Upside: +8.16%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $80.94
Upside: -9.81%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $24.42
Upside: +117.04%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $32.13
Upside: +77.40%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $16.40
Upside: -42.06%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $132.94
Upside: -21.77%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $13.96
Upside: +329.80%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $92.90
Upside: +23.79%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $392.31
Upside: -61.76%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $107.22
Upside: -57.10%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $466.86
Upside: -48.24%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $105.73
Upside: +67.41%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $178.43
Upside: -17.61%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.51
Upside: +158.28%